Clinical Trials Logo
  1. Home
  2. Sexually Transmitted Infections
  3. NCT01842100
  4. Details
NCT01842100 Clinical Trial

To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy

Sexually Transmitted Infections Clinical Trial

Official title:
To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01842100
Other study ID # QMHRC99 - 15 RC/B/121
Secondary ID
Status Completed
Phase N/A
First received April 21, 2013
Last updated April 24, 2013
Start date September 1999
Est. completion date February 2006

Study information
Verified date April 2013
Source The University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority Hong Kong: Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (HKU/HA HKW IRB)
Study type Interventional

Clinical Trial Summary

Screen-and-treat approach reduces postabortal pelvic inflammatory disease after induced abortion, and at the same time alters women's sexual behavior and prevents further re-infection by sexually transmitted infections when compared to the universal antibiotic prophylaxis strategy.

Description:

While universal antibiotic prophylaxis during induced abortion has been proven to reduce postabortal pelvic inflammatory diseases, screen-and-treat approach has the potential benefit of altering women's sexual behavior and preventing further re-infection by sexually transmitted infections. We conducted a randomized controlled trial to compare the effect of the two approaches in preventing postabortal pelvic inflammatory disease and the women's sexual behavior.

Recruitment information / eligibility
Status Completed
Enrollment 2193
Est. completion date February 2006
Est. primary completion date February 2006
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- women requesting for induced abortion in the gynecology clinic

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Intervention

Drug:
• Universal antibiotic prophylaxis
100 mg twice daily for 7 days starting on the day of induced abortion
Other:
• Screen-and-treat
Specific antibiotic treatment was only given if the women was found to have sexually transmitted infection(s) on screening.

Locations
Country Name City State
China Queen Mary Hospital Hong Kong Hong Kong

Sponsors (1)
Lead Sponsor Collaborator
The University of Hong Kong

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Rate of postabortal inflammatory disease 6 weeks after induced abortion. 6 weeks after induced abortion. No
Secondary Rate of re-infection by sexually transmitted infections 24 weeks after induced abortion. 24 weeks after induced abortion. No
Secondary Proportion of women having abstinence from sexual intercourse or using condom at 6 weeks, 24 weeks and 1 year after induced abortion. 6 weeks, 24 weeks and 1 year after induced abortion No
See also
  Status Clinical Trial Phase
Completed NCT01144871 - Parental Knowledge and Attitudes of Confidential Sexually Transmitted Infections (STI) Services for Teens N/A
Completed NCT04661566 - Optimizing a Multi-Modal Intervention to Reduce Health-Risking Sexual Behaviors: Component Selection N/A
Completed NCT04867798 - Transgender Men and HIV in Uganda: PrEP Uptake and Persistence
Active, not recruiting NCT04328025 - Peer-Delivered HIV Self-Testing, STI Self-Sampling and PrEP for Transgender Women in Uganda N/A
Completed NCT02509572 - Improvement of STI Detection in Adolescent Emergency Department Patients N/A
Active, not recruiting NCT04758390 - A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women N/A
Completed NCT03528135 - Project PRIDE (Promoting Resilience In Discriminatory Environments) N/A
Recruiting NCT04547413 - STI/HIV Intervention Behavioral Intervention Program N/A
Completed NCT01784809 - The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders Phase 2
Completed NCT01136850 - Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea Phase 3
Completed NCT02461940 - STI/HIV Prevention Intervention for Adolescents in Singapore N/A
Completed NCT00469547 - 62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides Phase 1
Completed NCT01285349 - HIV/STI Prevention for Drug-Involved Couples N/A
Completed NCT02391233 - Multimedia WORTH With Black Drug-Involved Women on Probation N/A
Completed NCT02183909 - Connecting Resources for Urban Sexual Health N/A
Completed NCT02882607 - Peer Groups for Healthy Pregnancy & HIV Prevention for Young Malawian Women N/A
Completed NCT00362375 - Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women Phase 1/Phase 2
Active, not recruiting NCT04710784 - A Pragmatic Trial to Expand Youth-friendly HIV Self-testing N/A
Recruiting NCT06223165 - Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot N/A
Completed NCT05319613 - Reducing Disparities in Rural HIV Prevention N/A